115 algorithm-development-"Multiple"-"Prof"-"Simons-Foundation" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
stimulating environment as part of the Oxford Motor Neuron Disease Centre and will be based in the Kavli Institute for Nanoscience Discovery. This is an exciting opportunity to contribute to the development
-
to reveal cells, genes, proteins and pathways underlying the infection process, parasite development and interaction with the hosts. These findings are further validated by in situ localization of gene
-
to the University. This full-time post is initially fixed-term for 12 months with possible extension for a further 12 months. The Podium Institute constitutes a world-unique ecosystem within which to develop and
-
learning and computational methods. In addition, candidates should provide evidence of creative and critical thinking as applied to the development and execution of a cohesive programme of research. A
-
an ambitious, motivated, and hard-working Postdoctoral Research Associate to join Dr Antoni Wrobel’s lab. Our small research team investigates molecular mechanisms underlying viral evolution and host changes
-
challenges, from reducing our carbon emissions to developing vaccines during a pandemic. The Department of Psychiatry is based on the Warneford Hospital site in Oxford – a friendly, welcoming place of work
-
. The scale of these assays will be large, and this post will require excellent organization and planning skills. Previous experience with qPCR , flow cytometry and experimental evolution would also be
-
learning, at the intersection of reinforcement learning, deep learning and computer vision, in order to train effective robotic agents in simulation. You should hold a relevant PhD/DPhil (or near completion
-
advanced functional genomics, transcriptomics, and proteomics approaches, you will develop novel therapeutic strategies for cancer immunotherapy. You will be responsible for managing your own academic
-
relevant assays to interrogate dysregulation induced in iPS-neurons by exposure to material from Alzheimer’s brains. You will develop an iPS-neuronal-microglial co-culture screening platform that can assess